Showing 18,301 - 18,320 results of 21,342 for search '(( significant risks decrease ) OR ( significant decrease decrease ))', query time: 0.40s Refine Results
  1. 18301

    DataSheet1_Cell-bound complement activation products in antiphospholipid antibody-positive patients without other systemic autoimmune rheumatic diseases.pdf by Doruk Erkan (9170430)

    Published 2024
    “…At baseline, 4/31 (13%) patients had decreased C3/C4, while 7/29 (24%) had elevated BC4d, 11/33 (33%) EC4d, and 12/32 (38%) PC4d. …”
  2. 18302

    Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…</p>Conclusion<p>MRAs significantly reduce the risk of adverse cardiovascular events in patients with heart failure and contribute to LVEF improvement. …”
  3. 18303

    Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…</p>Conclusion<p>MRAs significantly reduce the risk of adverse cardiovascular events in patients with heart failure and contribute to LVEF improvement. …”
  4. 18304

    Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…</p>Conclusion<p>MRAs significantly reduce the risk of adverse cardiovascular events in patients with heart failure and contribute to LVEF improvement. …”
  5. 18305

    Supplementary Material for: Effect of gonadotropin dose reduction during COH on progesterone levels and embryo outcomes in women undergoing IVF/ICSI-ET with GnRH-A protocol by figshare admin karger (2628495)

    Published 2025
    “…The proportion of patients with P ≥ 1.5 ng/ml was significantly lower in the gonadotropin dose reduction group compared to the control group (22.7% vs. 29.9%, P=0.003).Multivariable logistic regression indicated that dose reduction decreased the risk of progesterone elevation [OR=0.535, 95% CI: 0.404-0.709]. …”
  6. 18306

    Image 1_Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients.png by Zhi Lin (281756)

    Published 2025
    “…</p>Results<p>Profound dyslipidemia was observed post-transplantation, with over 60% of patients developing significantly decreased high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) compared to baseline. …”
  7. 18307

    Supplementary Material for: Impact of the apolipoprotein E ε4 allele on cognition and omega-3 fatty acid levels in the plasma membrane of red blood cells in healthy elderly Japanes... by figshare admin karger (2628495)

    Published 2025
    “…The ratio of docosahexaenoic acid (DHA) to arachidonic acid was significantly decreased, and the erythrocyte eicosapentaenoic acid (EPA) and DHA levels tended to be reduced in APOE4 carriers. …”
  8. 18308

    Table 1_Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients.docx by Zhi Lin (281756)

    Published 2025
    “…</p>Results<p>Profound dyslipidemia was observed post-transplantation, with over 60% of patients developing significantly decreased high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) compared to baseline. …”
  9. 18309

    Data Sheet 1_Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease.docx by Yifan Zhang (119570)

    Published 2025
    “…The MR analysis results showed a positive correlation between higher genetic predictions of dopamine 3-O-sulfate levels and the risk of Parkinson’s disease. In contrast, the reverse MR analysis found that Parkinson’s disease susceptibility significantly increased dopamine 3-O-sulfate levels.…”
  10. 18310

    Nyamsuren, I., Mitchell, E., and Tsay, J. (April 27 - May 2, 2025), <i>Learning Sign Language with Real-Time Kinematic Feedback</i> [Poster Presentation]. The Annual Meeting of the... by Indranil Nyamsuren (21498833)

    Published 2025
    “…This growing demand emphasizes the significance of sign language—not just as a communication tool, but as a key to ensuring equal participation in society.…”
  11. 18311

    HK2 regulates mRNA translation in melanoma cells. by Ana Luisa Dian (22258504)

    Published 2025
    “…HK2 depletion significantly decreased the abundance of <i>SOX10</i>, <i>CDH2</i>, and <i>WNT5A</i> mRNAs extracted from polysome fractions, but not in total RNAs. …”
  12. 18312

    VB2 cell fate analysis of <i>hlh-17</i>, <i>hlh-31</i>, and <i>hlh-32</i> mutant animals. by G. Robert Aguilar (13889674)

    Published 2025
    “…(<b>B</b>) In <i>hlh-17/31/32</i><sup>null</sup> mutants, <i>flp-32(syb4374)</i> reporter allele expression in VB2 is decreased, reaching the same level of expression as that in VB1. …”
  13. 18313

    Supplementary Material for: Using smartphone data to frequently measure atopic dermatitis severity and understand triggers: A decentralized 12-week observational study by Ali Z. (5634332)

    Published 2024
    “…Decreasing temperature was significantly associated with higher POEM (estimate -0.18, p=0.012) and EASI score (estimate -0.14, p=0.007), but not with SCORAD. …”
  14. 18314

    Table 1_Ten-year outcomes of repeat keratoplasty for optical indications.docx by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  15. 18315

    Image 1_Ten-year outcomes of repeat keratoplasty for optical indications.png by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  16. 18316

    Table 5_Ten-year outcomes of repeat keratoplasty for optical indications.docx by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  17. 18317

    Table 2_Ten-year outcomes of repeat keratoplasty for optical indications.docx by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  18. 18318

    Table 3_Ten-year outcomes of repeat keratoplasty for optical indications.docx by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  19. 18319

    Table 4_Ten-year outcomes of repeat keratoplasty for optical indications.docx by Victoria Grace Dimacali (20597690)

    Published 2025
    “…Log-rank test showed higher survival of PK/EK compared to PK/PK (p = 0.002) and EK/PK (p = 0.009), and of EK/EK compared to PK/PK (p = 0.003) and EK/PK (p = 0.005). High-risk regrafts had significantly lower 10-year survival probabilities compared to non-high-risk regrafts (p = 0.045). …”
  20. 18320

    Image 8_Spatiotemporal trends of ischemic stroke burden attributable to PM2.5 from 1990 to 2021.pdf by Yunyan Lu (10699005)

    Published 2025
    “…The age-standardized rates (ASRs) of ischemic stroke linked to ambient PM2.5 slightly declined, while those associated with household PM2.5 significantly decreased over the past 32 years. The burden of ischemic stroke attributable to ambient and household PM2.5 exhibited considerable heterogeneity across 204 countries. …”